Tech Company Financing Transactions

Argolyn Bioscience Funding Round

Argolyn Bioscience secured a $15.8 million Series A venture capital round on 6/25/2007. Investors included Intersouth Partners, Quaker Partners and Amgen Ventures.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

2530 Meridian Pkwy. 200
Durham, NC 27713
USA

Phone

(919) 806-4634

Website

www.argolynbioscience.com

Email Address

[email protected]

Overview

Argolyn Bioscience, Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Nixon Ellis

        

Chief Scientific Officer

Thomas Dix

        

Browse more venture capital transactions:

Prev: 6/25/2007: MyTime Media venture capital transaction
Next: 6/25/2007: Advanced BioNutrition venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to record all VC transactions involving tech companies. All VC database entries on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary